BioConnection appoints Richard Sewalt as New Chief Commercial Officer
OSS, The Netherlands – 6 September 2024, BioConnection, a leading Dutch contract development and manufacturing organization (CDMO) in the pharmaceutical industry, today announced the appointment of Richard Sewalt as new Chief Commercial Officer [CCO]. With …